Additionally, PGM2L1 appears to regulate key pathways in CCA, including neutrophil infiltration, tumor metabolism, and the Wnt signaling pathway, all of which may contribute to tumor progression. The gene discussed is PGM2L1; the disease is cholangiocarcinoma.